Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.91% | -35.09% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.91% | -35.09% | -- | -- | -- |
| Cost of Revenue | -53.82% | -46.84% | -- | -- | -- |
| Gross Profit | -32.19% | -28.20% | -- | -- | -- |
| SG&A Expenses | -32.53% | -30.66% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.61% | -27.36% | -- | -- | -- |
| Operating Income | 27.02% | 27.01% | -- | -- | -- |
| Income Before Tax | 24.95% | 18.28% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.95% | 18.28% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.95% | 18.28% | -- | -- | -- |
| EBIT | 27.02% | 27.01% | -- | -- | -- |
| EBITDA | 27.62% | 26.74% | -- | -- | -- |
| EPS Basic | 86.98% | 80.08% | -- | -- | -- |
| Normalized Basic EPS | 87.09% | 82.26% | -- | -- | -- |
| EPS Diluted | 86.98% | 80.08% | -- | -- | -- |
| Normalized Diluted EPS | 87.09% | 82.26% | -- | -- | -- |
| Average Basic Shares Outstanding | 508.36% | 450.32% | -- | -- | -- |
| Average Diluted Shares Outstanding | 508.36% | 450.32% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |